Altre lingue Genpharmasec Limited

Azioni

ADIRASA

INE861N01036

Tempo differito Bombay S.E. Altri mercati azionari 07:02:55 05/07/2024			Variaz. 5gg	Var. 1 gen.
2,38 ^INR	-2,46%		+16,50%	-48,61%

24/05	Genpharmasec Limited riporta i risultati degli utili per l'intero anno terminato il 31 marzo 2024	CI
24/05	Genpharmasec Limited riporta i risultati degli utili per il quarto trimestre conclusosi il 31 marzo 2024	CI

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

Genpharmasec Limited Reports Earnings Results for the Full Year Ended March 31, 2024	24/05
Genpharmasec Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	24/05
Genpharmasec Limited Announces Appointment of Hardik Makwana as Company Secretary & Compliance Officer	27/03
Genpharmasec Limited Announces Resignation of Heta Shah as Company Secretary / Compliance Officer	20/03
Genpharmasec Limited Announces Resignation of Ulhas Narayan Deosthale from the Post of Executive Director	12/03
Genpharmasec Limited completed the acquisition of an unknown stake in Derren Healthcare Private Limited from the existing shareholder.	11/03
Genpharmasec Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	12/02
Genpharmasec Forms Subsidiary for Molecular Testing Services	29/01
Genpharmasec Limited Forms New Wholly Owned Subsidiary Company Namely Clinigenome India Private Limited	29/01
Genpharmasec Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	08/11
Genpharmasec to Acquire 70% Stake in Derren Healthcare for INR126.4 Million	20/09/23
Genpharmasec Limited signed a share purchase agreement to acquire an unknown stake in Derren Healthcare Private Limited from the existing shareholder for approximately INR 130 million.	19/09/23
Genpharmasec Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	11/08/23
Genpharmasec Sets Up Middle East Unit	14/07/23
Genpharmasec Limited Incorporates Foreign Subsidiary Namely Genpharmasec Middle East DMCC	14/07/23
Genpharmasec Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	26/05/23
Genpharmasec Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	10/02/23
Genpharmasec Limited Announces Board Changes	01/11/22
Genpharmasec Limited Announces CFO Changes	01/11/22
Genpharmasec Limited Appoints Heta Shah as Company Secretary and Compliance Officer, with Effect from October 7, 2022	07/10/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Genpharmasec Limited

Azioni

ADIRASA

INE861N01036

Altre lingue

Filtri